GlassScriptPhysician profile
Carmen O Doyle
NPI 1659590883
$816.42
in general payments reported to CMS, 2019-2025
8 companies · $86.13 in 2025
The $86.13 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.05 · 2022: $324 · 2023: $125 · 2024: $253 · 2025: $86.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $256.42 | 2022-2025 | Dupixent |
| Merz Pharmaceuticals, LLC | $228.63 | 2021-2023 | Xeomin |
| Optinose US, INC. | $131.99 | 2024 | |
| Glaxosmithkline, LLC. | $78.46 | 2022-2023 | Nucala |
| Medtronic, INC. | $44.73 | 2022-2023 | Sinuva |
| Kerecis Limited | $34.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbott Laboratories | $21.33 | 2025 | 2nd Gen Centrimag Primary Console |
| Smith+Nephew, INC. | $20.79 | 2024 | Tula, Halo, Rf20000 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmen Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.